Increasing tPa activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Xin, Hongqi ^a   Li, Yi ^a   Shen, Li Hong ^a   Liu, Xianshuang ^a   Wang, Xinli ^a   Zhang, Jing ^a   Pourabdollah Nejad, Siamak ^a   Zhang, Chunling ^a   Zhang, Li ^a   Jiang, Hao ^a   Zhang, Zheng Gang ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; OXYGEN; PHOSPHATE BUFFERED SALINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SYNAPTOPHYSIN; TISSUE PLASMINOGEN ACTIVATOR; GLUCOSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ATTENUATION; BRAIN NERVE CELL; COCULTURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MULTIPOTENT STEM CELL; MYELINATION; NERVE FIBER; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROKE; STROMA CELL; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BRAIN; C57BL MOUSE; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; MESODERM; METABOLISM; NERVE CELL; NEURITE; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RNA INTERFERENCE;

MUS;

ANIMALS; APOPTOSIS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION; GLUCOSE; HUMANS; IN SITU NICK-END LABELING; MESODERM; MICE; MICE, INBRED C57BL; MULTIPOTENT STEM CELLS; NEURITES; NEURONS; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STROKE; STROMAL CELLS; SYNAPTOPHYSIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77949354685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009027     Document Type: Article

References (102)

1. Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G, Fischer I (2005) Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035: 73-85.
2. Andrews EM, Tsai SY, Johnson SC, Farrer JR, Wagner JP, et al. (2008) Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp Neurol 211: 588-592.
3. Li Y, Chen J, Zhang CL, Wang L, Lu D, et al. (2005) Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49: 407-417.
4. Xin H, Li Y, Chen X, Chopp M (2006) Bone marrow stromal cells induce BMP2/4 production in oxygen-glucose-deprived astrocytes, which promotes an astrocytic phenotype in adult subventricular progenitor cells. J Neurosci Res 83: 1485-1493.
5. Chen X, Li Y, Wang L, Katakowski M, Zhang L, et al. (2002) Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22: 275-279.
6. Chen X, Katakowski M, Li Y, Lu D, Wang L, et al. (2002) Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 69: 687-691.
7. Li Y, Chen J, Chen XG, Wang L, Gautam SC, et al. (2002) Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59: 514-523.
8. Lu W, Tsirka SE (2002) Partial rescue of neural apoptosis in the Lurcher mutant mouse through elimination of tissue plasminogen activator. Development 129: 2043-2050.
9. Siao CJ, Tsirka SE (2002) Extracellular proteases and neuronal cell death. Cell Mol Biol (Noisy-le-grand) 48: 151-161.
10. Tsirka SE (2002) Tissue plasminogen activator as a modulator of neuronal survival and function. Biochem Soc Trans 30: 222-225.
11. Fok-Seang J, DiProspero NA, Meiners S, Muir E, Fawcett JW (1998) Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth. Eur J Neurosci 10: 2400-2415.
12. Vivien D, Buisson A (2000) Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab 20: 755-764.
13. Yepes M, Lawrence DA (2004) Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Thromb Haemost 91: 457-464.
14. Yepes M, Lawrence DA (2004) Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system? Trends Cardiovasc Med 14: 173-180.
15. Gravanis I, Tsirka SE (2005) Tissue plasminogen activator and glial function. Glia 49: 177-183.
16. Wu YP, Siao CJ, Lu W, Sung TC, Frohman MA, et al. (2000) The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 148: 1295-1304.
17. Yepes M, Lawrence DA (2004) New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp Biol Med (Maywood) 229: 1097-1104.
18. Nolin WB, Emmetsberger J, Bukhari N, Zhang Y, Levine JM, et al. (2008) tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2. Glia 56: 177-189.
19. Tzarfaty-Majar V, Lopez-Alemany R, Feinstein Y, Gombau L, Goldshmidt O, et al. (2001) Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix. J Biol Chem 276: 28233-28241.
20. Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50: 673-678.
21. Lawrence DA, Strandberg L, Ericson J, Ny T (1990) Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants. J Biol Chem 265: 20293-20301.
22. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, et al. (2008) Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 28: 468-481.
23. Gao Q, Li Y, Shen L, Zhang J, Zheng X, et al. (2008) Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro. Neuroscience 152: 646-655.
24. Shen LH, Li Y, Gao Q, Savant-Bhonsale S, Chopp M (2008) Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain. Glia 56: 1747-1754.
25. Oikawa K, Watanabe T, Miyamoto I, Higuchi S (2000) Determination, pharmacokinetics and protein binding of a novel tissue-type plasminogen activator, pamiteplase in human plasma. Xenobiotica 30: 993-1003.
26. Salthouse TN (1964) Luxol Fast Blue G as a Myelin Stain. Stain Technol 39: 123.
27. Ujike H, Takaki M, Kodama M, Kuroda S (2002) Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann N Y Acad Sci 965: 55-67.
28. Chopp M, Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1: 92-100.
29. Chen J, Li Y, Wang L, Zhang Z, Lu D, et al. (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005-1011.
30. Li Y, Chopp M, Chen J, Wang L, Gautam SC, et al. (2000) Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20: 1311-1319.
31. Lee J, Kuroda S, Shichinohe H, Ikeda J, Seki T, et al. (2003) Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology 23: 169-180.
32. Shichinohe H, Kuroda S, Yano S, Hida K, Iwasaki Y (2007) Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct. Brain Res 1183: 138-147.
33. Chopp M, Li Y, Chen J, Zhang R, Zhang Z (2008) Brain repair and recovery from stroke. European Neurology in press.
34. Chopp M, Li Y, Zhang ZG (2009) Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke 40: S143-145.
35. Chopp M, Li Y (2006) Functional recovery after stroke with cell-based therapy. In: Bhardwaj AAN, Kirsch JR, Traystman RJ, eds. Acute Stroke: Bench to Bedside Informa Healthcare USA, Inc. pp 473-480.
36. Chopp M, Li Y (2006) Transplantation of bone marrow stromal cells for treatment of central nervous system diseases. Adv Exp Med Biol 585: 49-64.
37. Chopp M, Li Y, Zhang J (2008) Plasticity and remodeling of brain. J Neurol Sci 265: 97-101.
38. Zhang J, Brodie C, Li Y, Zheng X, Roberts C, et al. (2009) Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis. J Neurol Sci 279: 30-38.
39. Li Y, Chopp M (2009) Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett 456: 120-123.
40. Zhang J, Li Y, Chen J, Cui Y, Lu M, et al. (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195: 16-26.
41. Zhang J, Li Y, Chen J, Yang M, Katakowski M, et al. (2004) Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 1030: 19-27.
42. Toshniwal PK, Firestone SL, Barlow GH, Tiku ML (1987) Characterization of astrocyte plasminogen activator. J Neurol Sci 80: 277-287.
43. Kucharewicz I, Kowal K, Buczko W, Bodzenta-Lukaszyk A (2003) The plasmin system in airway remodeling. Thromb Res 112: 1-7.
44. Teesalu T, Hinkkanen AE, Vaheri A (2001) Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am J Pathol 159: 2227-2237.
45. Lee SR, Lok J, Rosell A, Kim HY, Murata Y, et al. (2007) Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemia. Neuroscience 150: 50-57.
46. Yepes M, Sandkvist M, Wong MK, Coleman TA, Smith E, et al. (2000) Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96: 569-576.
47. Park L, Gallo EF, Anrather J, Wang G, Norris EH, et al. (2008) Key role of tissue plasminogen activator in neurovascular coupling. Proc Natl Acad Sci U S A 105: 1073-1078.
48. Barker PA (2009) Whither proBDNF? Nat Neurosci 12: 105-106.
49. Barnes P, Thomas KL (2008) Proteolysis of proBDNF is a key regulator in the formation of memory. PLoS ONE 3: e3248.
50. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, et al. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306: 487-491.
51. Bernd P (2008) The role of neurotrophins during early development. Gene Expr 14: 241-250.
52. Wozniak W (1993) Brain-derived neurotrophic factor (BDNF): role in neuronal development and survival. Folia Morphol (Warsz) 52: 173-181.
53. Fahnestock M, Yu G, Coughlin MD (2004) ProNGF: a neurotrophic or an apoptotic molecule? Prog Brain Res 146: 101-110.
54. Crutcher KA (1986) The role of growth factors in neuronal development and plasticity. CRC Crit Rev Clin Neurobiol 2: 297-333.
55. Edgar D (1985) Nerve growth factors and molecules of the extracellular matrix in neuronal development. J Cell Sci Suppl 3: 107-113.
56. Yamada K (2008) Endogenous modulators for drug dependence. Biol Pharm Bull 31: 1635-1638.
57. Aoki C, Bredt DS, Fenstemaker S, Lubin M (1998) The subcellular distribution of nitric oxide synthase relative to the NR1 subunit of NMDA receptors in the cerebral cortex. Prog Brain Res 118: 83-97.
58. Zhang N, Beuve A, Townes-Anderson E (2005) The nitric oxide-cGMP signaling pathway differentially regulates presynaptic structural plasticity in cone and rod cells. J Neurosci 25: 2761-2770.
59. Samson AL, Nevin ST, Croucher D, Niego B, Daniel PB, et al. (2008) Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J Neurochem 107: 1091-1101.
60. Wang X, Lee SR, Arai K, Lee SR, Tsuji K, et al. (2003) Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9: 1313-1317.
61. An J, Zhang C, Polavarapu R, Zhang X, Zhang X, et al. (2008) Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112: 2787-2794.
62. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, et al. (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14: 731-737.
63. Fredriksson L, Li H, Fieber C, Li X, Eriksson U (2004) Tissue plasminogen activator is a potent activator of PDGF-CC. Embo J 23: 3793-3802.
64. Reigstad LJ, Varhaug JE, Lillehaug JR (2005) Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. Febs J 272: 5723-5741.
65. Buisson A, Nicole O, Docagne F, Sartelet H, Mackenzie ET, et al. (1998) Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. Faseb J 12: 1683-1691.
66. Hino H, Akiyama H, Iseki E, Kato M, Kondo H, et al. (2001) Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues. Neurosci Lett 297: 105-108.
67. Peltonen S, Lassila R, Lepantalo M (1996) Increased circulating plasminogen activator inhibitor-1 in patients with patent femoro-distal venous bypass. Thromb Res 82: 369-377.
68. Liu RM (2008) Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal 10: 303-319.
69. Cramer SC, Chopp M (2000) Recovery recapitulates ontogeny. Trends Neurosci 23: 265-271.
70. Ahn MY, Zhang ZG, Tsang W, Chopp M (1999) Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain Res 837: 169-176.
71. Hua Y, Xi G, Keep RF, Wu J, Jiang Y, et al. (2002) Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 22: 55-61.
72. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM (2004) The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24: 945-963.
73. Kahles T, Foerch C, Sitzer M, Schroeter M, Steinmetz H, et al. (2005) Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent. Vascul Pharmacol 43: 254-259.
74. Rossi DJ, Brady JD, Mohr C (2007) Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 10: 1377-1386.
75. Ma DK, Ming GL, Song H (2005) Glial influences on neural stem cell development: cellular niches for adult neurogenesis. Curr Opin Neurobiol 15: 514-520.
76. Song H, Stevens CF, Gage FH (2002) Astroglia induce neurogenesis from adult neural stem cells. Nature 417: 39-44.
77. Sofroniew MV (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11: 400-407.
78. Siddiqui S, Horvat-Broecker A, Faissner A (2009) Comparative screening of glial cell types reveals extracellular matrix that inhibits retinal axon growth in a chondroitinase ABC-resistant fashion. Glia.
79. Matsui F, Oohira A (2004) Proteoglycans and injury of the central nervous system. Congenit Anom (Kyoto) 44: 181-188.
80. Shen LH, Li Y, Chen J, Cui Y, Zhang C, et al. (2007) One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke 38: 2150-2156.
81. Cafferty WB, Yang SH, Duffy PJ, Li S, Strittmatter SM (2007) Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 27: 2176-2185.
82. Tom VJ, Doller CM, Malouf AT, Silver J (2004) Astrocyte-associated fibronectin is critical for axonal regeneration in adult white matter. J Neurosci 24: 9282-9290.
83. Ribotta MG, Menet V, Privat A (2004) Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice. Acta Neurochir Suppl 89: 87-92.
84. Gabriel C, Ali C, Lesne S, Fernandez-Monreal M, Docagne F, et al. (2003) Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. Faseb J 17: 277-279.
85. Buisson A, Lesne S, Docagne F, Ali C, Nicole O, et al. (2003) Transforming growth factor-beta and ischemic brain injury. Cell Mol Neurobiol 23: 539-550.
86. Lee SR, Guo SZ, Scannevin RH, Magliaro BC, Rhodes KJ, et al. (2007) Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators. Neurosci Lett 417: 1-5.
87. Hardy SA, Maltman DJ, Przyborski SA (2008) Mesenchymal stem cells as mediators of neural differentiation. Curr Stem Cell Res Ther 3: 43-52.
88. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, et al. (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11: 96-104.
89. Ikeda N, Nonoguchi N, Zhao MZ, Watanabe T, Kajimoto Y, et al. (2005) Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 36: 2725-2730.
90. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, et al. (2004) BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9: 189-197.
91. Chen J, Li Y, Katakowski M, Chen X, Wang L, et al. (2003) Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73: 778-786.
92. Cui X, Chen J, Zacharek A, Roberts C, Savant-Bhonsale S, et al. (2008) Treatment of stroke with (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl) amino] diazen-1-ium-1, 2-diolate and bone marrow stromal cells upregulates angiopoietin-1/Tie2 and enhances neovascularization. Neuroscience 156: 155-164.
93. Phinney DG, Kopen G, Isaacson RL, Prockop DJ (1999) Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72: 570-585.
94. Shichinohe H, Kuroda S, Maruichi K, Osanai T, Sugiyama T, et al. (2009) Bone marrow stromal cells and bone marrow-derived mononuclear cells: Which are suitable as cell source of transplantation for mice infarct brain? Neuropathology.
95. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
96. Miskin R, Soreq H (1981) Sensitive autoradiographic quantification of electrophoretically separated proteases. Anal Biochem 118: 252-258.
97. Wang Y, Hand AR, Gillies C, Grunnet ML, Cone RE, et al. (1997) Morphologic evidence for a preferential storage of tissue plasminogen activator (t-PA) in perivascular axons of the rat uvea. Exp Eye Res 65: 105-116.
98. Braungart E, Magdolen V, Degitz K (2001) Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes. J Invest Dermatol 116: 778-784.
99. Zheng S, Yin ZQ, Zeng YX (2008) Developmental profile of tissue plasminogen activator in postnatal Long Evans rat visual cortex. Mol Vis 14: 975-982.
100. Wang L, Zhang ZG, Zhang RL, Jiao ZX, Wang Y, et al. (2006) Neurogenin 1 mediates erythropoietin enhanced differentiation of adult neural progenitor cells. J Cereb Blood Flow Metab 26: 556-564.
101. von Bohlen und Halbach O, Albrecht D (1998) Tracing of axonal connectivities in a combined slice preparation of rat brains-a study by rhodamine-dextran-amine-application in the lateral nucleus of the amygdala. J Neurosci Methods 81: 169-175.
102. Franklin KBJ, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic Press.